114 related articles for article (PubMed ID: 16292169)
1. [Spatial delimitation of low grade oligodendrogliomas].
Pallud J; Devaux B; Nataf F; Roux FX; Daumas-Duport C
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):254-9. PubMed ID: 16292169
[TBL] [Abstract][Full Text] [Related]
2. [MRI for oligodendrogliomas].
Brami-Zylberberg F; Grand S; Le Bas JF; Meder JF
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):273-85. PubMed ID: 16292172
[TBL] [Abstract][Full Text] [Related]
3. Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities.
Pallud J; Varlet P; Devaux B; Geha S; Badoual M; Deroulers C; Page P; Dezamis E; Daumas-Duport C; Roux FX
Neurology; 2010 May; 74(21):1724-31. PubMed ID: 20498440
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcome of oligodendrogliomas.
Lebrun C; Fontaine D; Ramaioli A; Vandenbos F; Chanalet S; Lonjon M; Michiels JF; Bourg V; Paquis P; Chatel M; Frenay M;
Neurology; 2004 May; 62(10):1783-7. PubMed ID: 15159478
[TBL] [Abstract][Full Text] [Related]
5. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
6. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
7. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
8. Multimodal
Karlberg A; Berntsen EM; Johansen H; Myrthue M; Skjulsvik AJ; Reinertsen I; Esmaeili M; Dai HY; Xiao Y; Rivaz H; Borghammer P; Solheim O; Eikenes L
World Neurosurg; 2017 Dec; 108():989.e1-989.e8. PubMed ID: 28844925
[TBL] [Abstract][Full Text] [Related]
9. Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.
Wagner MW; Poretti A; Huisman TA; Bosemani T
Childs Nerv Syst; 2015 Jun; 31(6):885-91. PubMed ID: 25813856
[TBL] [Abstract][Full Text] [Related]
10. Surgical target selection in cerebral glioma surgery: linking methionine (MET) PET image fusion and neuronavigation.
Roessler K; Gatterbauer B; Becherer A; Paul M; Kletter K; Prayer D; Hoeftberger R; Hainfellner J; Asenbaum S; Knosp E
Minim Invasive Neurosurg; 2007 Oct; 50(5):273-80. PubMed ID: 18058643
[TBL] [Abstract][Full Text] [Related]
11. Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas.
Gerin C; Pallud J; Deroulers C; Varlet P; Oppenheim C; Roux FX; Chrétien F; Thomas SR; Grammaticos B; Badoual M
Neuro Oncol; 2013 Oct; 15(10):1379-88. PubMed ID: 23771168
[TBL] [Abstract][Full Text] [Related]
12. Presurgical (99m)Tc-sestamibi brain SPET/CT versus SPET: a comparison with MRI and histological data in 33 patients with brain tumours.
Cecchin D; Chondrogiannis S; Della Puppa A; Rotilio A; Zustovich F; Manara R; Gardiman M; Berti F; Zucchetta P; Carollo C; Bui F
Nucl Med Commun; 2009 Sep; 30(9):660-8. PubMed ID: 19561554
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
14. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.
Pirzkall A; Nelson SJ; McKnight TR; Takahashi MM; Li X; Graves EE; Verhey LJ; Wara WW; Larson DA; Sneed PK
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1254-64. PubMed ID: 12128127
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
16. Pre- and post-surgery MRSI predictive value in adult oligodendroglioma prognosis.
Bund C; Lefebvre F; Schott R; Chenard MP; Lhermitte B; Cebula H; Kremer S; Proust F; Namer IJ
Magn Reson Imaging; 2018 Oct; 52():75-83. PubMed ID: 29902567
[TBL] [Abstract][Full Text] [Related]
17. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrogliomas in the CT/MR-era.
Leonardi MA; Lumenta CB
Acta Neurochir (Wien); 2001 Dec; 143(12):1195-203. PubMed ID: 11810382
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence-guided surgery in high grade gliomas using an exoscope system.
Belloch JP; Rovira V; Llácer JL; Riesgo PA; Cremades A
Acta Neurochir (Wien); 2014 Apr; 156(4):653-60. PubMed ID: 24468884
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging and histopathology of cerebral gliomas.
Watanabe M; Tanaka R; Takeda N
Neuroradiology; 1992; 34(6):463-9. PubMed ID: 1436452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
